Tan Yann Chong
Chief Executive Officer at Nuevocor Pte Ltd.
Profile
Tan Yann Chong is the founder of Nuevocor Pte Ltd.
Prior to founding Nuevocor, he worked as the Managing Director at Esco Ventures Pte Ltd from 2021 to 2022.
He completed his undergraduate degree at Duke University in 2007 and his graduate degree at Stanford University in 2012.
Tan Yann Chong active positions
| Companies | Position | Start |
|---|---|---|
Nuevocor Pte Ltd.
 Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Chief Executive Officer | - |
Former positions of Tan Yann Chong
| Companies | Position | End |
|---|---|---|
Esco Ventures Pte Ltd.
 Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Private Equity Investor | 2022-07-31 |
Training of Tan Yann Chong
| Duke University | Undergraduate Degree |
| Stanford University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Esco Ventures Pte Ltd.
Esco Ventures Pte Ltd. Investment ManagersFinance Esco Ventures Pte Ltd (Esco Ventures) is a venture capital firm founded in 2014 by Mr. Dr Nir Arbel and XiangQian (XQ) Lin. The firm is headquartered in Singapore. | Finance |
Nuevocor Pte Ltd.
Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Nuevocor Pte Ltd. is a biotechnology company based in Singapore, Singapore. The Singaporean company pioneers an innovative pathway-centric approach to developing genetic medicines for heart conditions known as cardiomyopathies. Nuevocor designs genetic medicines to target the biomechanical root cause of these diseases by harnessing their Prosia mechanobiology platform. The company's approach surpasses the limitations of traditional gene therapy, which focuses on individual gene mutations, to treat defects within shared disease pathways across multiple genetic cardiomyopathies. This enables them to extend their impact to broader patient populations. The company was founded by Colin Stewart, Mark Kay, Jianming Jiang, Yin Loon Lee, Tan Yann Chong, Brian Burke. Tan Yann Chong has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Tan Yann Chong
